Early Access — free while we kick the tires
EdgarHawk

OPGN OPGEN INC Insider Trading

3 filings analyzed · Latest 2025-07-30
Insider buys
3
Insider sells
0
Unique insiders
1
Direction
Net buying

Historically, medium-priority insider buys have outperformed the S&P 500 by a median ~1% over the 30 days after filing — the edge is concentrated in that first month (n ≈ 7,520, 2022-2026). Past results don't predict the future. How we measure this ↗

July 2025
2025-07-30
medium
1,000 shares
$4,790
@ $4.79
Significance 2/10

10% Owner AEI Capital Ltd purchases 1,000 OPGN shares at $4.79; adds to 7.65M position amid 5 prior OPGN buys all showing -100% 90d returns.

AEI Capital Ltd, a 10% shareholder, purchased 1,000 shares of OPGEN at $4.79 on 2025-07-30, increasing holdings from 7,645,603 to 7,646,603 shares. The current price of $4.70 is -9.3% from the 52-week high and -3.7% over 30 days. However, this buy follows a deeply concerning pattern: all 5 of AEI's prior purchases at OPGN (between August 8–29, 2024) each resulted in -100% 90-day returns, with 0 of 5 buys showing positive post-purchase performance. Across AEI's broader open-market history, 6 prior buys averaged -100.0% 90-day return with a 0.00% win rate. The lack of success in timing previous OPGN purchases raises material questions about whether continued accumulation at these price levels represents informed capital allocation or a pattern of purchasing into declining positions.

December 2024
2024-12-10
critical
2,400,000 shares
$1,916,326,200,000
@ $798,469.25
Significance 9/10

AEI Capital (10% owner) purchases 2,400,000 shares in 2 transactions for $1,916.3B; stock has collapsed -83.3% from 52-week high and trades at $1.30 vs. blended buy price of $798,469.25

AEI Capital executed 2 separate purchases totaling 2,400,000 shares for $1,916,326,200,000.00 on 2024-08-05 and 2024-08-08 at a blended average price of $798,469.25. The current market price of $1.30 stands -83.3% below the 52-week high and represents a devastating drawdown relative to the transaction prices paid. AEI Capital's cross-ticker track record shows 4 prior buys with an average 90-day return of -100.0% and a 0.00% win rate, while its 5 prior trades at OPGN have uniformly underperformed post-purchase: all 4 prior buys at this ticker show -100.0% returns at the 90-day mark, with only 1 of 5 prior trades well-timed overall. OPGN's fundamentals are severely distressed—the company was unprofitable over its most recent full fiscal year, generated only $28,000 in latest quarterly revenue against a $13.1M market cap, and the stock has declined -35.6% over 90 days and -23.5% over 30 days, creating a pattern where AEI Capital's timing and selection judgment at this ticker has been persistently poor.

October 2024
2024-10-08
critical
5,245,603 shares
$11,130,140,980,409
@ $2,121,803.91
Significance 9/10

10% owner AEI Capital acquired 5.25M shares ($11.1B invested) vs sold 2.40M ($1.9B) in Aug 2024; stock now down 83.6% from 52-week high to $1.95.

AEI Capital, a 10% shareholder, executed 4 separate purchases totaling 5,245,603 shares for $11,130,140,980,409.00 across August 2024, while simultaneously divesting 2,400,000 shares for $1,916,326,200,000.00 in net accumulation of 2,845,603 shares (+59.3% increase in holdings). The per-share prices in the purchases (ranging from $428,724 on 2024-08-13 to $2,724,490 on 2024-08-16) were dramatically higher than the current market price of $1.95, which stands 83.6% below the 52-week high of $11.90. OPGN is currently unprofitable with negative net income of $-1,576,349.00 in the latest quarter and a market cap of only $16,293,217.20, indicating severe fundamental distress. The insider's prior trades at this ticker show a pattern of immediate underwater positions (30d return of -100.0% on both the 2024-08-05 and 2024-08-08 buys), and the cross-ticker track record shows the same pattern (2 prior buys with average 30d return of -100.0%). This filing documents a substantial capital deployment into a deeply distressed, unprofitable microcap that has since collapsed in valuation, raising questions about execution risk, purchase timing, and the underlying strategic rationale for such aggressive accumulation.

More Health Services companies

Get alerts for OPGN

Add OPGN to your watchlist and we'll email you when an insider files a Form 4 — with our AI's significance score and a plain-English read of what it means.

Sign up — free during early access